This Masters program in France, Italy, Germany offers fully funded. The application deadline is 15 March 2026.
KEY DETAILS - Location: France, Italy, Germany - Program level: Masters - Funding: Fully Funded - Deadline: 15 March 2026
ELIGIBILITY - A bachelor’s degree in biology, life sciences, or a closely related field is required, or an equivalent degree. - Strong academic credentials are required, and those with previous laboratory or research experience are given preference. - Undergraduate students in their last year may apply as long as they present certified documentation of their graduation by July 2026. - Must exhibit competency in the English language using one of the recognized criteria listed below:. - TOEFL: 93 (iBT), 237 (computer), or 580 (paper). - IELTS: 6.5 is the minimum overall band score. - CEFR: B2 or above. - Cambridge: C2 Proficiency or C1 Advanced. - A language certificate from the university if the prior degree was earned in English. - Applicants who have finished their degree at an English-medium university may not need to provide proof of English.
BENEFITS - Tuition fees are completely waived. - Living expenses are covered by a monthly grant of about €1,400. - Assistance with airfare and other travel-related costs. - Assistance with lodging and food expenses. - Coverage for health and medical insurance during the course of the program. - The costs of applying for a visa and obtaining a residency permit are entirely reimbursed. - Career Opportunities:. - MemBioMed graduates are qualified for positions in:. - Research and development in biomedicine. - The biotechnology and pharmaceutical sectors. - Clinical research and neuroscience. - Scholarly investigation and doctoral studies (PhD). - Innovation in healthcare and diagnostic technologies.
